FDA Approves Blujepa for Treating Urinary Tract Infections in Women
The US Food and Drug Administration (FDA) has approved a new antibiotic, gepotidacin, under the brand name Blujepa, to treat uncomplicated urinary tract infections (UTIs) in females 12 and older. The pill is expected to be available in the second half of 2025. About half of all women will experience a UTI at some point … Read more